Antitumour activity and schedule dependency of 8-chloroadenosine-3′,5′-monophosphate (8-ClcAMP) against human tumour xenografts

This publication has 7 references indexed in Scilit:

• Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing mice
  Annals of Oncology, 1996
• 8-Chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line
  British Journal of Cancer, 1995
• Growth inhibition by 8-chloro cyclic AMP of human HT29 colorectal and ZR-75-1 breast carcinoma xenografts is associated with selective modulation of protein kinase A isoenzymes
  European Journal Of Cancer, 1995
• 8-Cl-cAMP induces truncation and down-regulation of the RI alpha subunit and up-regulation of the RII beta subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells.
  Published by Elsevier ,1993
• Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine
  Anti-Cancer Drugs, 1992
• Role of site-selective cAMP analogs in the control and reversal of malignancy
  Pharmacology & Therapeutics, 1991
• Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemia
  The American Journal of Medicine, 1987